Completed PHASE4 INTERVENTIONAL 2-arm NCT00917241

Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone

Prevention Relapse of Graves' Disease by Treatment With Intrathyroid Injection of Dexamethasone

Sponsor: Xiao-Ming Mao

Updated 5 times since 2017 Last updated: May 2, 2013 Started: Jun 30, 2004 Primary completion: Dec 31, 2008 Completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Graves' Disease and is currently completed. Xiao-Ming Mao leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xiao-Ming Mao

Data source: Nanjing Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.